Oppenheimer upgraded Ovid Therapeutics (OVID) to Outperform from Perform with a $4 price target The firm says OV329’s promise is “quite real” ...

Apple Inc. was downgraded to perform from outperform at Oppenheimer, in the latest sign of caution building ahead of the ...

Oppenheimer analyst Martin Yang downgraded Apple (AAPL) to Perform from Outperform with no price target as the firm lowered its FY26 EPS ...

DeepSeek’s breakthrough is “a wake up call” that adds to market concentration risks, Oppenheimer and team say: a reminder ...

Global markets are concentrated in three major ways: U.S. stocks have come to dominate global equity indices, technology as a ...

Oppenheimer made a significant adjustment to Zentalis Pharmaceuticals' (NASDAQ:ZNTL) price target, reducing it from $20.00 to ...

In a remarkable display of market confidence, Oppenheimer Holdings Inc (NYSE:OPY). stock has reached an all-time high, ...

The tech-led selloff in US equities at the start of this week was just a blip, given the positive outlook for the economy, ...

The Doomsday Clock is now at 89 seconds to midnight and we’ve never been closer to annihilation. Here’s everything you need ...

Bobby saw skepticism of vaccines as a way to generate attention and controversy for himself, get book deals [and] lucrative ...

The Trump administration has increased detentions of undocumented immigrants. But is it going after the right ones?

Consumer spend across the UK home entertainment sector rose to £5.1bn in 2024, the highest ever recorded figure for the ...